Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)

Clinical trial NCT04746911 · COMPLETED

Trial details

NCT number: NCT04746911
Sponsor: Arcutis Biotherapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Plaque Psoriasis

Start date: 2021-03-01
Primary completion: 2022-05-11
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.